Orgenesis, Inc. (ORGS)
0.3438
-0.11
(-23.61%)
USD |
OTCM |
Jun 16, 16:00
Orgenesis Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | -6.77K% |
| September 30, 2024 | -2.67K% |
| June 30, 2024 | -3.81K% |
| March 31, 2024 | -7.10K% |
| December 31, 2023 | -4.01K% |
| September 30, 2023 | -3.39K% |
| June 30, 2023 | -27.60K% |
| March 31, 2023 | -16.46K% |
| December 31, 2022 | -9.34% |
| September 30, 2022 | -17.63% |
| June 30, 2022 | -76.27% |
| March 31, 2022 | -55.42% |
| December 31, 2021 | -72.81% |
| September 30, 2021 | -117.0% |
| June 30, 2021 | -25.84% |
| March 31, 2021 | -1.76% |
| December 31, 2020 | -2.24K% |
| September 30, 2020 | -553.3% |
| June 30, 2020 | -1.55K% |
| March 31, 2020 | -373.5% |
| Date | Value |
|---|---|
| December 31, 2019 | -1.06K% |
| September 30, 2019 | -339.7% |
| June 30, 2019 | -430.9% |
| March 31, 2019 | -1.92K% |
| November 30, 2018 | -118.6% |
| August 31, 2018 | -68.54% |
| May 31, 2018 | -62.10% |
| February 28, 2018 | -207.8% |
| November 30, 2017 | -25.35% |
| August 31, 2017 | -153.8% |
| May 31, 2017 | -108.4% |
| February 28, 2017 | -330.8% |
| November 30, 2016 | -152.0% |
| August 31, 2016 | -143.0% |
| May 31, 2016 | -343.8% |
| February 29, 2016 | 14.80% |
| November 30, 2015 | -78.73% |
| August 31, 2015 | -172.6% |
| May 31, 2015 | -133.7% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 21.02% |
| BioCryst Pharmaceuticals, Inc. | -461.5% |
| Imunon, Inc. | -- |
| Curis, Inc. | -- |